I Bella Perfect, which operates three aesthetic medical clinics in Malaysia, filed on Tuesday with the SEC to raise up to $9 million in an initial public offering.
The company plans to raise $9 million by offering 1.9 million shares at a price range of $4 to $6. At the midpoint of the proposed range, I Bella Perfect would command a market cap of $108 million.
I Bella Perfect operates three aesthetic medical clinics in the central and southern regions of Malaysia, providing non-invasive and minimally invasive procedures including facial and skin treatments, body contouring, and laser therapies. The company offers services such as skin tightening, botulinum toxin injections, and filler injections, while also selling a range of five branded skincare products including facial cleansers and creams formulated by original equipment manufacturers. In the year ended March 31, 2025, it served 5,985 customers across its Kuala Lumpur, Selangor, and Johor locations.
The Kuala Lumpur, Malaysia-based company was founded in 2012 and booked $5 million in revenue for the 12 months ended March 31, 2025. It plans to list on the Nasdaq under the symbol IBL. I Bella Perfect filed confidentially on June 30, 2025. Cathay Securities is the sole bookrunner on the deal.
